Slater & Gordon have recently been retained by the The Safe Food Institute (SFI) to review the release and regulation of genetically modified organisms within Australia. The SFI has been established to conduct and support research into food safety. This submission puts before the review a body of material the SFI submits mucst be considered. The Gene Technology Act (GT Act), the role of federal and state governments and their authorities in regulating the release of genetically modified organisms (GMOs) will be a central focus of that reivew.
Given the extremely short review period allocated by the Gene Technology Ministerial Council (GTMC), this submission is not a comprehensive review. Specifically this submission seeks to place before the GTMC a body of scientific evidence of harm arising from the release and or use of GMOs which illustrates the concerns which the SFI considers this review must take into account in considering the future operation of the GT Act if the object of the GT Act is to be achieved.
We note that the object of the GT Act is defined below:
The object of the Act is to protect the health and safety of people and the environment from risks posed by, or as a result of, gene technology by identifying those risks and managing them by regulating certain dealings with genetically modified organisms (GMO's). The Act establishes a regulatory framework through which its object is to be achieved. This framework provides for a precautionary approach and an efficient and effective system for the application of gene technologies that is intended to operate in conjunction with other Australian Government and State Territory regulatory shcemes relevant to GMOs and GM products.
The SFI submits that the GT Act has comprehensively failed in its object to protect public health and safety, and the environment, and our economy from harm caused by the licensed release of GMOs. The GT Act also fails to establish an effective regulatory framework or take a precautionry approach to achieve its object.
Instead, the GT Act enables regulators to issue licensed to GMO proponents who are not required to prove theur products are safe. The onus of proof of danger or harm is left the the Australian public who are the unwilling and uninformed experimental subjects exposed to the often unlabelled consumption of GMOs. Even when this evidence of harm is provided, the regulators (and therefore the GT Act) fail to operate to protect against further harm.
It is the view of the SFI that the growing body of concerns and scientific evidence justifies the recommendation of a comprehensive and independent legal or parliamentary review of the operation and effectiveness of the GT Act. The SFI submits, pending the outcome of such an enquiry, that the GTMC should impose a moratorium on any further approval under the GT Act and conduct an urgent safety review of all current dealings with GMOs licensed under the GT Act to date.
Practice Group Leader
Commercial & Project Litigation
SLATER & GORDON LIMITED
Summary of evidence provided by The Safe Food Institute
Appendix A: 2 Key Scientific Papers on Gmo Safety Issues.............................................................................4
Appendix B: 70 Key Scientific Papers on Gmo Safety Issues...........................................................................5
Appendix C: Gmo Indistry Blocks Research.....................................................................................................9
Appendix D: GMO Industry Attacks on Scientists...........................................................................................10
Appendix E: GMO Industry & Government Ignore Expert Report...................................................................11
Appendix F: Government Sell Out Of Science To Gmo Commerce..................................................................13
Appendix A: 2 Key Scientific Papers on Gmo Safety Issues
These are two recent papers that strike to the core of safety concerns regarding the release of GMO's. Both of these are attached in the PFD form for the GTMC to consider.
Appendix B: 70 Key Scientific Papers on Gmo Safety Issues
- Aris, A and Leblanc, S. (2011) "Maternal and fetal exposure to pesticides associated to genetically modified foods in Eastern Townships of Quebec, Canada." Reproductive Toxicology, 2011 May; 31(4):528-33. Epub 2011 Feb 18.
- Antoniou, M et al. (2011) "Roundup and birth defects: Is the public being kept in the dark?". Earth Open Source.
We have not attached these papers rather given the references so GTMC can access them.
- Agodi, A et al. (2006) "Detection of genetically modified DNA sequences in milk from The Italian Market". International Journal of Hygiene and Environmental Health, 209, 81-88.
- Benachour N, Sipahutar H, Moslemi S. et al. "Time- and dose- dependent effects of roundup on human embryonic and placental cells". Arch Environ Contam Toxicol. 2007;53:126-33
- Benachour, N. and Seralini, G-E. 2008, "Glyphosate Formulations Induce Apoptosis and Necrosis in Human Umbilical, Embryonic, and Placental Cells", Chemical Research in Toxicology, DOI: 10.1021/tx800218n. Publication Date (Web): December 23, 2008
- Bernstein, I.L., Bernstein, J.A., Miller, M., Tierzieva, S., Bernsrein, D.I., Lummus, Z., Selgrade, M.K., Doerfler, D.L. and Seligy, V.L. (1999). "Immune responses in farm workers after exposure to Bacillus thuringiensis pesticdes", Environmental Health Perspectives 107, 575-582
- Chowdhury, E.H., et al (2003) "Detection of corn intrinsic and recombinant DNA fragments and Cry1Ab protein in the gastrointestinal contents of pigs fed genetically modified corn Bt11" Journal of Animal Science 81, 2546-2551.
- Cisterna B, Flach F, Vecchio L, Barabino SM, Battistelli A, Martin TE, Malatesta M, Biggiogera M. 2008, "Can a genetically- modified organism-containing diet influence embryo development? Aprelinanary study on pre-implementation mouse ambryos". Eur J Histochem. 2008 Oct-Dec; 52(4):263-7.
- Duggan et al., 2003, "Fate of genetically modified maize DNA in the oral cavity and rument of sheep", British Journal of Nutrition, 2003,
- Dutton, A., H. Klein, J. Romeis, and F. Bigler, 2002, "Uptake of Bt-toxin by herbivores feeding on transgenic maize and consequences for the predator Chrysoperia carnea," Ecological Entomology 27 (2002): 441-7
- Ermakova, I.V. 2006. "Genetically modified soy leads to the decrease of weight and high mortality of rat pups of the first generation. Preliminary studies," Ecosinform 1 (2006): 4-9.
- Ermakova, I.V. 2009. "Influence of soy with gene EPSPS CP4 on the physiological state and reproductive functions of rats in the first two generations," Russian Academy of Natural Sciences, "Modern problems of science and education" No 5, 2009. UCD: 612.82, 57.02
- Ewen S.W. and Pusztai A., 1999 "Effect of diets containing genetically modifies potatoes expressing Galanthus nivalis lectin on rat small intestine". Lancet, col. 354, pp. 1353-1354.
- Fares NH, El-Sayed AK. 1998 "Fine structural changes in the ileum of mice fed on delta-endotoxin-treated potatoes and transgenic potatoes". Nat Toxins. 6: 219-33.
- Finamore A, Roselli M, Britti S, Monastra G, Ambra R, Turrini A and Mengheri E. (2008). "Instestinal and peripheral immune response to MON810 maize ingestion in weaning and old mice". J Agric Food Chem, 16 November 2008
- Fu, TJ. et al. (2002) " Digestibility of food allergens and nonallergenic proteins in simulated gastric fluid and simulated intestinal fluid - A comparative study". Journal of Agricultural Food Chemistry, 50, 7154-7160.
- Guerrero, GG. W.M Russel and L. Moreno-Fierros, 2007: "Analysis of the cellular immune response induced by Bacillus thuringiensis Cry1Ac toxins in mice: Effect of the hydrophobic mofit from diptheria toxin". Molecular Immunology 44, 1209-1217 (2007).
- Kilic, A. and M. T. Akay (2008). " A three generation study with genetically modified Bt corn in rats: Biochemical and histopathological investigation". Food Chem. Toxicol. 46(3): 1164-1170.
- Kroghsbo S, Madsen C, Poulsen M, Schroder M, Kvist PH, Taylor M, Gatehouse A, Shu Q, Knudsen I. "Immunotoxicological studies of genetically modified rice expressing PHA-E lectin or Bt toxin in Wistar rats". Toxicology. 2008 Mar 12;245(1-2):24-3
- Lutz, B. et al. (2005) "Degradation of Cry1Ab protein from genetically modified maize in the bovine gastrointestinal tract". Journal of Agricultural Food Chemistry, Published on Web, 10.1021/jf0492222x, American Chemical Society.
- Malatesta, M., F Perdoni, G Santin, S Battistelli, S Muller, M Biggiogera (2008). "Hepatoma tissue culture (HTC) cells as a model for investigating the effects of low concentrations of herbicide on cell structure and function". Toxicol in Vitro. 2008 Sep 18; : 18835430
- Malatesta M, Caloraloni C, Gavaudon S. et al. 2002, "Ultrastructural morphometrical and immunocytochemical analyses of hepatocyte nuclei from mice fed on genetically modified soybean". Cell Struct Function. 2002; 27:173-178
- Malatesta M, Biggiogera M, Manuali E. et al. 2003, "Fine structural analyses of pancreatic acinar cell nuclei from mice fed on genetically modified soybean". Eur J Histochem. 2003; 47:385-388
- Manuela Malatesta, Federica Boraldi, Giulia Annovi, Beatrice Baldelli, Serafina Battistelli, Marco Biggiogera, Daniela Quaglino. (2008) "A long-term study on femalemice fed on a genetically modified soybean: effects on liver ageing". Histochem Cell Biol. 2008 Jul 22; : 18648843
- Malatesta, M. et al. (2002b) "Ultrastructural analysis of pancreatic acinar cells from mice fed on genetically modified soybean". Journal of Anatomy. 201, 409-446.
- Mazza R, Soave M, Morlacchini M, Piva G, Marocco A.(2005) "Assessing the transfer of genetically modified DNA fed from feed to animal tissues". Transgenic Res. 2005 Oct;14(5):775-84.
- Netherwood, T (2004) "Assessing the survival of transgenic plant DNA in the human gastrointestinal tract". Nature Biotechnology, 22, 204-209.
- Nordgard L, Gronsberg IM, Hegge B, Fenton K, Nielsen KM, Bardocz S, Pusztai A and Traavik T. 2009. A examination of the fate of feed-derived DNA in various tissue samples of actively growing rats, pregnant rats and their foeti. Submitted
- Prescott V.E., Campbell P.M., Moore A., Mattes J., Rothenberg M.E., Foster P.S., Higgins T.J. and Hogan S.P. 2005, "Transgenic expression of bean alpha-amylase inhibitor in peas results in altered structure and immunogenicity", J Agric Food Chem., vol 53, pp. 9023-9030, ., 2005
- Pryme, IF and Rolf Lembcke, 2003, "In Vivo Studies on Possible Health Consequences of Genetically Modified Food and Feed - with Particular Regard to Ingredients Consisting of Genetically Modified Plan Materials," Nutrition and Health 17(2003): 1-8.
- Seralini GE, de Vendomois JS, Cellier D, Sultan C, Buiatti M, Gallagher L, Antoniou M, Dronamraju KR. "How Subchronic and Chronic Health Effects can be Neglected for GMOs, Pesticides or Chemicals". Int J Biol Sci 2009; 5:438-443.
- Seralini GE, Cellier D, Spiroux de Vendomois J. 2007, "New analysis of a rat feeling study with a genetically modified maize reveals signs of hepatorenal toxicity". Arch Environ Contam Toxicol. 2007;52:596-602
- Sharma R, Alexander TW, John SJ, Forster RJ, McAllister TA. 2004, "Relative stability of transgene DNA fragments from GM rapeseed in mixed ruminal cultures". Br J Nutr. 2004 May;91(5): 1699-709
- Sharma R, Damgaard D, Alexander TW, Dugan ME, Aalhus JL, Stanford K, McAllister TA. (2006) "Detection of transgenic and endogenous plant DNA in digesta and tissues of sheep and pigs fed Roundup Ready canola meal". J Agric Food Chem. 2006 Mar 8;54(5): 1699-709.
- Tayabali AF and Seligy VL. 2000, "Human cell exposure assaya of Bacillus thuringiensis commercial insecticides: production of Bacillus cereus-like cytolytic effects from outgrowth of spores". Environ Health Perspect 108: 919-930, (2000).
- Trabalza-Marinucci M, Brandi G, Rondini C, Avellini L, Giammarini C, Costarelli S, Acuti G, Orlandi C, Filippini G, Chiaradia E, Malatesta M, Crotti S, Anotonini C, Amagliani G, Manuali E, Mastrogiacomo AR, Moscati L, Haouet MN, Gaiti A, Magnani M (2008). "A three year longitudinal study on the effects of a diet containing genetically modified Bt176 maise on the health status and performance on sheep". Livestock Sci 113:178-190
- Tudisco R, Lombardi P, Bovera F, d'Angelo D, Cutrignelli MI, Mastellone V, Terzi V, Avallone L, Infascelli F (2006) "Genetically modified soys bean effects by enzymatic analysis." Amin Sci 82:193-199
- RI. Vazquez, L. Moreno-Fierros, L. Neri-Bazan, G.A. De la Riva and R. Lopez-Revilla: "Bacillus thuringiensis Cry1Ac protoxin is a potent systemic and mucosal adjuvant". Scandanavian Journal of Immunology 49, 578-584 (1999);
- Vasquez Padron, R.I., Moreno Fierros, L., Neri Bazan, L., De la Riva, G.A. and Lopez Revilla, R. "Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice" Life Sciences 64, 1897-1912. (1999);
- Vazquez Padron, R.I., Moreno-Fierros, L., Neri Bazan, L., Martinez-Gil, A.F., de la Riva, G.A. and Lopez-Revilla, R. (2000) "Characterization of the mucosal and sytemic immune response induced by Cry1Ac protein from Bacillus thuringiensis HD 73 in mice". Brazilian Journal of Medical and Biological Research 33, 147-155 (2000);
- Vazquez Padron, R.I., Gonzalez Cabrera, J., Garcia Tovar, C., Neri Bazan, L., Lopez Revilla, R., Hernandez, M., Morena Fierros, L. and De la Riva, G.A. (2000) "Cry1Ac protoxin from Bacillus thuringiensis sp. kurstaki HD73 beinds surface protiens in the mouse small intestine". Biochemical and Biophysical Research Communications 271, 54-58 (2000)).
- Vazquez Padron, R.I. Et al. (2000) "Charaterization of the musocal and systemic immune response induced by Cry1Ac protein from the Bacillus thuringiensis HD 73 in mice" Brazilian Journal of Medical and Biological Research 33, 147-155.
- Vecchio L, Cisterna B, Malatesta M, Matrin TE, Biggiogera M (2004) "Ultrastructural analysis of testes from mice fed on genetically modified soybean". Eur J Histochem 48:449-453
- Velimirov A, Binter C and Zentek J. (2008) "Biological effects of transgenic maize NK603xMON810 fed in long term reproduction studies in mice". Report, Forschungsberichte der Sektion IV, Band 3. Institut fur Ernahrung, and Forschingsinttitut fur biologischen Landbau, Vienna, Australia, November 2008/
- Vnedomois, JS, Francois Roullier, Dominique Cellier and Gilles- Eric Seralini. 2009, "A Comparison of the Effects of Three GM Corn Varieties on Mammalian Health". International Journal of Biological Sciences 2009; 5(7):706-726
- Yum, HY. (2005) "Genetically modified and wild soybeans: An immunologic comparison". Allergy and Asthma Proceedings, 26, 210-216.
- Carman J. 2004, "Is GM Food Safe to Eat?" In: Hindmarsh R, Lawrence G, editors. Recoding Nature Critical Perspectives on Genetic Engineering. Sydney UNSW Press; 2004. p. 82-93.
- Cummins J and Ho MW. 2006 "GM crops for health?" ISIS Report, 24 September 2006, submitted to Codex Alimentarius public consultation
- Domingo JL. (2000) Health risks of genetically modified foods: many opinions but few data. Science 288, 1748-1749.
- Domingo, JL. 2007, "Toxicity studies of genetically modified plants: a review of the published literature". Crit Rev Food Sci Nutr. 2007;47(8):721-33
- Dona, A, and Arvanitoyannis, IS, 2009, "Health Riscks of Genetically Modified Foods", Critical Reviews in Food Science and Nutrition, 49:164-175 (2009)2
- Ermakova, I.V. 2007, "Experimental Evidence of GMO Hazards," Presentation at Scientists for a GM Free Eurpoe, EU Parliament, Brussels, June 12, 2007
- Freese, W. "GE crop impacts health evaluation: a critique of US regulation of GE crops.....a case study of BT corm" FoE, US publication
- Freese, W. 2001. "The StarLink Affair, Submission by Friends of the Earth to the FIFRA Scientific Advisory Panel considering Assessment of Additional Scientific Information Concerning StarLink Corn," July 17-19, 2001
- Doug Gurian-Sherman, "Holes in the Biotech Safety Net, FDA Policy Does Not Assure the Safety of Genetically Engineered Foods," Center for Science in the Public Interest, http://www.cspinet.org/new/_pdf/fda_report__final.pdf
- Heinemann, J.A. 2009 "Report on animals exposed to GM ingredients in animal feed" (July 2009) Gendora / Commerce Commission of New Zealand
- Ho, Mae-wan (2002) THE BEST KEPT SECRETS OF GM CROPS, Witness Statement to ACRE (Open hearing on the T25 GM maize risk assessment.)
- Ho MW and Cummins J. 2004, "Gm food and feed not fit for man or beast", ISIS Report, ISP Briefing to UK Parliament, 7 May 2004.
- Ho, Mae-wan and Cummins Joe, 2009, "New evidence links CaMV 35S promoter to HIV transcription," Microbial Ecology in Health and Disease. 2009; 21: 172-174
- Ho, Mae-wan, Cummins Joe and Saunders, Peter , 2007, "GM food nightmare unfolding in the regulatory sham', Microbial Ecology in Health and Disease, 1 - 12 (2007)
- Ho MW and Steinbrecher RA. 1998. "Fatal flaws in food safety assessment: critiquw of the joint FAO/WHO Biotechnology and Food Safety Report. Environmental & Nutritional Interations 1998, 2, 51-84.
- Marshall, A. 2007. GM soybeans and health safety - a controversy reexamined. Nature Biotechnology 25, 981-987 (2007) doi:10.1038/ nbt0907-981
- Maessen, GDF. 1997. Genomic stability and stability of expression in genetically modified plants. Acta Botanica Neerlandica 46(1) pp 3-24
- Novotny E. 2004. "Animals avoid GM food, for good reasons". Science in Society 21, 9-11, 2004.
- Pusztai, A and S.Bardocz, 2006: "GMO in animal nutrition: potential benefits and risks". In "Biology of Nutrition in Growing Animals" (ed. Mosenthin, R. Zentek, J.and Zebrowska, T.) 2006 Elsevier Limited, pp. 513-540).
- Pusztai, A. et al. (2003) Genetically Modified Foods: Potential Human Health Effects. In: "Food Safety: Contaiminants and Toxins (ed. JPF D'Mello) pp. 347-372. CAB International, Waalingford Oxon, UK.
- Quist, D., and Traavik, T., 2006. Safety assessment of GMOs: Human risks and research needs. Proceedings of the International workshop on biosafety: Environmental Impacts of Safety Regulation of Genetically Modified Organisms, Nanjing, China, China Environmental Press, p. 11-21.
- Seralini, G-E 2005. "Genome fluidity and health risks for GMOs." Epigenetics, Transgenic Plans and Risk Assessment, Conference Proceedings, Frankfurt, 2005.)
- Snow, A. et al. (2005) "Genetically engineered organisms and the environment: Current status and recommendations". Ecological Applications, 15, 377-404.
- Traavik T. 2008. "GMOs and their unmodified counterparts: substantially equivalent or different?" Pp 32-34, in: Breckling B, Reuter H and Verhoeven R: Implications of GM-Crop Cultivation at Large Spatial Scales, Theorie in fer Okologie vol. 14, Peter Lang, Frankfurt, 2008 (ISBN 978-3-631-58939-7)
- Traavik, T. and Jack Heinemann, (2006) "Genetic Engineering and Omitted Health Research: Still No Answers to Ageing Questions". 2006. Genok -- Centre for Biosafety
- Wilson, AK, Latham, JR and Steinbrecher, RA, 2006. "Transformation-induced mutations in transgenic plants - Vol. 23, December 2006, pp.209-237
- Wolfanberger, LL. & Phifer, PR. (2000) The ecological risks and benfits of genetically engineered plants. Science, 290, 2088-2093.
The above papers relate only to the direct and indirect effects of the consumption of GM food and feed - i.e. evidence of (1) GM plant toxicology (this would include all animal feeding, immuntoxicity, inhalation etc trials) and (2) evidence of potential harm from the indirect effects of GM plants through inseparable or unavoidable production methods (e.g. the effects of added Roundup residues which are unique to Roundup Ready plants or possibly other HT plants). Some papers discuss the survival of DNA from GM plants in the mammal digestive system, since there are obvious health implications.
We do not include papers which show environmental damage, relating to GM plant toxicity to animals in the food web (these may result in environmental harm or increase the evidence of potential human toxicities) and relating to potential harm to the food web from the indirect effects of GM plants through inseparable or unavoidable production methods (this could include the rise in glyphosate resistance weeds that also increase the chance of their toxins contaminating human food supplies).
The papers towards the end of this list are recommended reviews wish summarise earlier published raw data - and look for cause and effect relationships -- but which do not necessarily report new experimental data.
Appendix C: Gmo Industry Blocks Research
Pro-GM journal Nature Biotech journal in October 2009, critized the GM industry for blocking research:
"Are the crops industry's strong-arm tactics and close-fisted attitude to sharing seeds holding back independent research and undermining public acceptance of transgenic crops?"
Pro-GM journal Scientific American in August 2009, also critized the GM industry for blocking research:
"Scientists must ask corporations for permission before publishing independent research on genetically modified crops. That restriction must end"
To access GM seeds and crops for research is a legal and practical challenge, which has blocked research of evidence of harm.
Appendix D: GMO Indistry Attacks On Scientists
Arpad Pusztai (8 September 1930) is a Hungarian-born biochemist and nutritionist who spent 36 years at the Rowett Research Institute in Aberdeen, Scotland. He is a world expert on plant lectins, authoring 270 papers and three books on the subject. In 1998 Pusztai publicly announced that the results of his research showed feeding genetically modified potatoes to rats had negative effects on their stomach lining and immune system. This led to Puztai being suspended and his annual contract was not renewed. Their resulting controversy became known ar the Pusztai affair.
Nature journal in September 2009, criticzised GM scientists abuse: i.e.
"Papers suggesting that biotech crops might harm the environment attact a hail of abuse from other scientists, Emily Waltz asks if the ciritcs fight fair."
"These strikes are launches from within the scientific community and can sometimes be emotional and personal; heated rhetoric that dismisses papers and can even, as in Rosi-Marshall's case, accuse scientists of misconduct. "The response we got - it went through your jugular," says Rosi-Marshall.
Amnesty reports, in August 2010, the violent harrassment of Professor Andres Cassasco for his 2009 research, on the negative effects of glyphosate, on embryos (glyphosate causes birth defects and is used in 70% of GM crops); ie,
"(Prof Carrasco's) ...talk was suspended because the delegation was attacked by a group of around 100 people who threatened them and beat them. One person has since suffered from lower bosy paralysis after being hit on his spine, and another is undergoing neurological examinations after receiving blows to the head. The former provincial Sub-Secretary of Human Rights, Marcelo Salgado, was struck in the face and left unconscious. Dr Carrasco and his colleagues shut themselves in a car, and were surrounded by people making violent threats and beating the car for two hours. Members of the community were injusred and a journalist's camera equipment was damaged."
Appendix E: GMO Industry & Government Ignore Expert Report
The 2009 IAASTD report, an intergovernmental process supported by over 400 experts under the co-sponsorship of the FAO, GEF, UNDP, UNEP, UNESCO, the World Bank and WHO, stated:
"the way the world grows its food will have to change radically to better serve the poor and hungry if the world is to cope with the growing population and climate change while avoiding social breakdown and environmental collapse.";
"Assessment of modern biotechnology is lagged behind development; information can be anecdotal and contradictory, and uncertainty on benefits and harms is unavoidable. There is a wide range of perspectives on the environmental, human health and economic risks and benefits of modern biotechnology, many of which are as yet unknown." (SR Summary, p. 14)
"The application of modern biotechnology outside containment, such as the use of GM crops is much more contentious. For example, data based on some years and come GM crops indicate highly variable 10-33% yield gains in come plances and yield declines in others." (SR Summary, p. 14)
Professor Jack Heinemann co-authored the biotechnology section of the 2009 IAASTD Synthesis Report. In 2004, Monsanto submirred its GM high lysine maize to FSANZ (Food Standards Australia and New Zealand - national food safety regulator). In December 2007 FSANZ approved GM high lysine maize as safe for human consumption.
Heinemann's group made multiple submissions to FSANZ which were taken up by regulators in EU member states. Among the issues raised were risks of cancer, diabetes and Alzheimer's disease/
The EU regulators' submission to EFSA (European Food Safety Authority) were often based on Heinemann's work. The outcome caused EFSA to ask for some of the same safety tests that Heinemann's had attempted to get FSANZ to require. EFSA's request for safety information resulted in Monsanto withdrawing a GM product from EFSA consideration, rather than supply the results of these tests.
FSANZ maintains there is no safety issue with LY038, and that it was withdrawn from Europe purely for commercial reasons.
"Monsanto estimated the street value of LY038, was going to be US$1 billion a year. Do we really believe that a market of US$!bn a year is too small from Monsanto? I don't. The European Food Safety Authority requested more safety data from Monsanto."
At the end of April 2009, two letters were sent to EFSA by Monsanto's European subsidiary company Renessen, withdrawing applications originally subitted in 2005 and requesting the return of all dossier material (varietal characterization, experimental protocols, and test results) which was submitted with the applications for cultivation, animal feed and human feed. EFSA acceded to this request, making it impossible for any future independent researchers to analyse the Monsanto / Renessen data.
Dr Brian John of GM Free Cymru has dealt extensively on this issue with EFSA, and summarizes Heinemann submission of FSANZ / EFSA as follows:
The Monsanto dossiers included rigged research and false assumptions in the reported experiments; a failure to offer any test results based on cooked or processed corn [the way humans, but not animals, eat it]; a failure to test the whole GM plant in feeding trials; confusing and contradictory characterizations of the GM varieties and proteins; a fraudulent mixing of GM strains during trials; a pooling of crop data so as much as to mask undesirable effects in experiments; feeding trials too short to reveal true physiological changes in animal tissues; and the choice of an irrelevant, unrelated corn variety as the control group for comparison with the GM lines, with the clear intention of hiding potentially serious differences in composition or side effects on animals.
The Codex guidelines for the testing of GM crops were thus comprehensively broken by Monsanto's subsidiary Renessen, and were not enforced by the regulators in the USA, Canada, Australia and New Zealand. All in all, this amounted to blatant scientific fraud by the applicants, and a cynical failure to enforce the rules, and to protect the public, by the regulators.
Appendix F: Government Sell Out Of Science To Gmo Commerce
Dr Don Lotter comments on the failure of science, in the International Journal of Sociology of Agriculture and Food (IJSAF):
At the core of this failure appears to be the restructuring of research university science programs in the past 25 years from a non-proprietary 'public goods' approach to one based on dependence on private industry. Additional ramifications of this shift that have been factors in the transgenics issue are:
tolerance by the scientific community of bias against (and mistreatment of) non- compliant scientists, whose work results in negative findings for transgenics, including editorial decisions by peer-reviewed journals, as well as tolerance of
- biotechnology industry manipulation of the information environment;
- monopolization of the make-up of expert scientific bodies on transgenics by pro-
- industry scientists with vested interests in transgenics;
- deficient scientific protocols, bias, and possible fraul in industry-sponsored and industry-conducted safety testing of transgenic foods; and
- increasing politically and commercially driven mnipulation of science within federal regulatory bodies such as the FDA.
Landes Bioscience in March/April 2010, published an article titled Conducting public-sector research on commercialized transgenic seed, criticizing the GM industry:
"(GM)...industry partners may unduly influence the way research is designed and disseminated."
Stop selling out science to commerce
04 November 2009 by Stuart Parkinson and Chris Langley
Magazine issue 2733.
DO COMMERCIAL pressures have a nagative impact on science? This debate has been raging for so long that it usually raised little more than a shrug of indifference.
That is no longer a defensible response, A new report from our organisation, Scientists for Global Responsibility (SGR), exposed problems so serious that we can no longer afford to be indifference to them.
The report looks at the impact of five commercial sectors on science and technology over the past 20 years. The damaging influence of two of these, pharmaceuticals and tobacco, has been noted before. But we also looked at the oil and gas, defence and biotech sectors, which have been subjected to less scrutiny.
We found a wide range of disturbing commercial influences on science, and evidence that similat problems are occuring across academic disciplines.
Over the past two decades, government policy in the US, UK and elsewhere has fundamentally altered the academic landscape in a drive for profit. Universities have been pushed to adopt a much more commercial mindset, from taking out patents to prioritising research that promises short-term economic gains. The rapid spread of partnerships between businesses and universities has led to come disciplines becoming so intertwined with industry that few academics are able to retain their independence.
Chemical engineering and geology and strongly linked to oil companies, for example, and it is hard to find an engineering department in the UK which does not receive funding from the arms industry. And many life sciences departments have extensive links with the biotechnology and pharmaceutical industries.
This creates enormous potential for conflicts of interest. The problem has long been recognised in medical research, and journals are starting to crack down on it, but in other diciplines the problems are rarely even discussed, let alone acted upon.
Such problems are a major concern because they can undermine the quality and reliability of research. This is perhaps best illustrated by "sponsorship bias", where research generated results that suit the funder (The Journal of the American Medical Association, col 290, p 921). Another well-documented problem is the failure to report results unfavourable to the funder.
Research is also undermined by misleading messages put out by industry-funded lobby groups. Again, these tactics are well known from tobacco and oil industries, with their deliberate questioning of health research and sponsorship of climate sceptics. Less attantion has been given to the funding of some patient groups by pharmaceutical comapies and the (sometimes covert) use of PR companies by the biotechnology industry in the debate over genetically modified crops.
This does not bode well for public dicsussions on the risks of synthetic biology.
Another cornerstone of science that is being eroded is the freedom to set the public research agenda so that it serves the public interest. Governments are increasingly focused on delivering competitiveness, and business interests are able to exert pressure on funding bodies through representatived on their boards. As a result, environment and social problems and "blue-sky" research commonly lose out to short-term commercial gain.
For example, genetics now dominated agricultural science, not least because genetic technologies are highly patentable. This not only dominated privately funded research, but also steers publicly funded research away from work that takes a different approach or explores low-tech solutions.
As a result, "low-input" agricultural, which requires minimal use of the chemical fertilisers and pesticides and is cheaper and more useful to poorer farmers, is largely overlooked. Similarly, research on how to improve food distribution received inadequate support.
Another example os research on security issues, which is overwhelmingly focused on new military technology. Research into understanding the roots of conflict, or to support negotiation and reconciliation programmes, receives a tiny fraction of the tens of billions of dollars spent globally on developing military hardware. And most of that is public money.
Put bluntly, much publicly funded science is no longer being done in the public interest. Despite this, policy-makers are complacent and argue that any damaging effects of commercial influence are minor.
In contrast, many scientists are noticing the effects and becoming discomforted by them. Some are starting to speak out. For example, staff at the Open University in the UK are pusging for new ethical standards for business partnerships following the university's involvement in a major military contract.
However, these campaigns are few and far between. There is a strong incentive for scientists not to make a fuss if their department receives industry funds. This is strengthened by the contractual requirements for secrecy that often come with industry partnerships.
To defend independent science, reform is needed, from the level of government policy down to that of the research study. To this end, SGR is making recommendations. These include: the open publication of all funding arrangements between academia and business; ethical standards for business-university partnerships; proper handling of conflicts of interests by journals; more involvement of the public in setting research priorities; and a change in government policies which prioritise research with short-term commercial proirities above all else.
Scientists must now voice their concerns publicly in order that policy-makers hear them. They could do worse than follow the example set by campaigners at the Open University.
Stuart Parkinson and Chris Langley are authors of the SGR report Science and the Corporate Agenda, which can be downloaded from sgr.org.uk
Original submission in PDF format (PDF 769 KB)
In this section
- Occasional papers series
- Plasma Fractionation Review
- Regulatory Plan 2007-08
- Regulatory Plan 2008-09
- Regulatory Plan 2006-07
- Department of Health Reconciliation Action Plan
- PHERP Review Reports
- Margaret River Consumer for GM Free Food Submission to the review Gene Technology Act 2000
- 2002 Reviews of the National HIV/AIDS and Hepatitis C Strategies and Strategic Research
- 2006 Aged Care Homes Survey
- 2006 – 2007 Jurisdictional Summary Report against the National Strategic Framework for Aboriginal and Torres Strait Islander Health (NSFATSIH)
- A National Aboriginal Health Strategy: An Evaluation 1994
- Alcohol and other drugs: a handbook for health professionals
- Alerting the community to the link between illicit drugs and mental illness: developmental research
- An analysis of research on preventing falls and falls injury in older people: Community, residential care and hospital settings (2004 update)
- Anorexia nervosa: Australian treatment guide for consumers and carers, 2005
- Building on success 1: a review of gay and other homosexually active men's HIV/AIDS education in Australia
- Building on success 2: towards a national strategy for HIV/AIDS health promotion for gay and other homosexually active men
- Building on success 3: the Commonwealth Government response to towards national strategy for HIV/AIDS health promotion for gay and other homosexually active men
- COAG mental health early intervention measure - early childhood component: study to scope potential service delivery
- Coping with depression: Australian treatment guide for consumers and carers, 2005
- Council Of Grain Grower Organisations submission to the Gene Technology Act 2000 Review
- Deakin University submission to the Gene Technology Act 2000 review
- Deep vein thrombosis and air travel
- Department of Health and Ageing (DoHA) - Medicare Australia Memorandum of Understanding (MoU)
- Discussion Document Towards a Fourth National HIV/AIDS Strategy April 1999
- Drug and Alcohol Service Report (DASR): 2006-2007 Key Results
- Drug and Alcohol Service Report (DASR): 2007-2008 Key Results
- Evidence of effective interventions to improve the social and environmental factors impacting on health: Informing the development of Indigenous Community Agreements
- Falls prevention activities for older people: a national stocktake
- Gene technology Act 2000 review from Guy Izzett
- gettin em n keepin em
- Government response to the House of Representatives Inquiry into Indigenous health: 'Health is life'
- Innovative grants program: project summaries
- MAIF Guidelines - Marketing Of Infant Formulas Via Electronic Media
- Measuring Remoteness: Accessibility/Remoteness Index of Australia (ARIA) Revised Edition. Occasional Papers: New Series Number 14
- National evaluation of the Sharing Health Care Initiative demonstration projects
- National HIV/AIDS Strategy 2005-2008: Implementation Plan
- National Strategic Framework for Aboriginal and Torres Strait Islander Health Context July 2003
- National strategy for heart, stroke and vascular health in Australia
- Panic disorder and agoraphobia: Australian treatment guide for consumers and carers, 2005
- Principles for the consideration of interactions with health care professionals for the purpose of interpreting the MAIF Agreement
- Private Sector Outreach Services - Review of Private Sector Outreach Services Legislation
- Public discussion paper - Adoption of the Globally Harmonised System for Classification and Labelling of Chemicals in Respect to Domestic and Consumer Chemicals Including Pesticides
- Quality Use of Pathology Program (QUPP) Historical Reports
- Reforming the Australian
health care system:
the role of government. Occasional Papers: New Series Number 1
- Regulatory Plan 2009-10
- Regulatory Plan 2010-11
- Regulatory Plan 2011-2012
- Review of 2011 Gene Technology ACT (2000) - Public Submission
- Review of the Gene Technology Act 2000
- Review of the Gene Technology Act 2000 by Anne Goddard
- Review of the Gene Technology Act 2000 from I F Turnbull
- Review of the Gene Technology Act 2000 from Slater & Gordon Lawyers on behalf of The Safe Food Institute
- Royal Perth Hospital Comments on the Gene Technology Review 2000
- Self-harm: Australian treatment guide for consumers and carers, 2005
- Stigma and discrimination
- Strong Fathers Strong Families
- Submission by Anne Goddard regarding Terms of Reference in the Gene Technology Act 2000
- Submission by Dr Monica Leggett to the Gene Technology Act 2000 review
- Submission by the Office of the Gene Technology Regulator to the Review of the Gene Technology Act 2000
- Submission by The University of Newcastle for the 2011 Review of the Gene Technology Act 2000
- Submission from Bayer CropScience to the Gene Technology Act 2000 Review
- Submission from AgForce to the Statutory Review of the Gene Technology Act 2000
- Submission from Agrifood Awareness Australia Limited reviewing the Gene Technology Act 2000
- Submission from an Individual to the Review of Gene Technology Act 2000
- Submission from an Individual to the Review of the Gene Technology Act 2000
- Submission from AusBiotech to the 2011 Review of the Gene Technology Act 2000 (the Act)
- Submission from Beatrice Ludwig to the 2011 Review of the Gene Technology Act
- Submission from Croplife Australia to the Review of the Gene Technology Act 2000
- Submission from Department of Agriculture, Fisheries and Foresty to the Review of the Gene Technology Act 2000
- Submission from Elizabeth Hamilton to the 2011 Review of the Gene Technology Act 2000
- Submission from Graham Wearne to the Gene Technology Act 2000 Review
- Submission from Individuals at the Institutional Biosafety Committee to the Gene Technology Act 2000 Review
- Submission from Individuals to the Review of Gene Technology Act 2000
- Submission from Monsanto to the Review of the Gene Technology Act 2000
- Submission from Nuseed Australia to the Review of the Gene Technology Act 2000
- Submission from Peter Olson to the Review of Gene Technology Act 2000
- Submission from Queensland Institute of Medical Research to the Review of Gene Technology Act 2000
- Submission from the Australian Seed Federation to the Statutory Review of the Gene Technology Act 2000
- Submission from the Department of Innovation, Industry, Science and Research and The Commonealth Scientific and Industrial Research Organisation to the 2011 Review of the Gene Technology Act (2000)
- Submission from the Gene Technology Interdepartmental Committee to the Review of the Gene Technology Act 2000
- Submission from the GM-free Australia Alliance to the Review of the Gene Technology Act 2000
- Submission from the Grains Research and Development Corporation to the 2011 Review of the Gene Technology Act 2000
- Submission from the National Association for Sustainable Agriculture Australia WA Inc to the Review of the Gene Technology Act 2000
- Submission from the National Farmers' Federation review to the Gene Technology Act 2000
- Submission from the Producers Forum to the Review of the Gene Technology Act 2000
- Submission from the Western Australian Farmers Federation Review of the Gene Technology Act 2000
- Submission to the Gene Technology Act 2000 Review by Mary Gardner
- Submission to the Gene Technology Act 2000 Review from the Minister for Primary Industries and Water
- Submission to the Review of Gene Technology Act 2000 from Phil Aitken
- Submission to the Review of Gene Technology Act 2000 from Organic and Biodynamic Meats
- Submission to the Review of Gene Technology Act 2000 from Tracey Skippings
- Sumbission from Individuals from the Wambyn Organic Olive Farm for the Gene Technology Act 2000
- Sumission to the Department of Health and Ageing from the Pioneer Hi-Bred Australia Pty Ltd to the Review of the Gene Technology Act 2000 (the Act)
- Technology, Health and Health Care. Occasional Papers: Health Financing Series Volume 5
- The Ageing Australian Population and Future Health Costs: 1996-2051. Occasional Papers: New Series Number 7
- The Australian Government Response to the 2002 Reviews of the National HIV/AIDS and Hepatitis C Strategies
- The Dairy Industry Submission to the Statutory Review of the Gene Technology Acy 2000
- The National Hepatitis C Strategy 2005-2008
- The National Slips and Falls Prevention Project
- The Quality of Australian Healthcare: Current Issues and Future Directions. Occasional Papers: Health Financing Series Volume 6
- The Use of Antibiotics in Food-Producing Animals: Antibiotic-Resistant Bacteria in Animals and Humans
- Training frontline workers: young people, alcohol and other drugs
- Using Mathematical Models to Assess Responses to an Outbreak of an Emerged Viral Respiratory Disease
- Valuing the past ... investing in the future- Evaluation of the National HIV /AIDS Strategy 1993-94 to 1995-96
- Trachoma Surveillance Report 2006 to 2010
- Regulatory Plan 2005-06
- Regulatory Plan 2004-05
- Regulatory Plan 2003-04